The Emerging World of JAK Inhibitors

The Janus Kinase inhibitors are a new emerging class of small molecules. These target the Janus Kinase proteins located on the cell membrane. Janus Kinase proteins regulate the cellular transcription of several proteins and act as mediators in several cytokine pathways. Dysregulation in these cytok...

Full description

Saved in:
Bibliographic Details
Main Author: Shraddha Uprety
Format: Article
Language:English
Published: Society of Dermatologists, Venereologists and Leprologists of Nepal (SODVELON) 2024-10-01
Series:Nepal Journal of Dermatology, Venereology & Leprology
Subjects:
Online Access:https://www.nepjol.info/index.php/NJDVL/article/view/68527
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849227538613665792
author Shraddha Uprety
author_facet Shraddha Uprety
author_sort Shraddha Uprety
collection DOAJ
description The Janus Kinase inhibitors are a new emerging class of small molecules. These target the Janus Kinase proteins located on the cell membrane. Janus Kinase proteins regulate the cellular transcription of several proteins and act as mediators in several cytokine pathways. Dysregulation in these cytokine pathways is responsible for disorders like alopecia areata, psoriasis, vitiligo, lichen planus, and more in dermatology. Contrary to the injectable biologics, these Janus kinase inhibitors can be taken per oral route and have greater patient acceptability. In this review, we seek to discuss the various indications of Janus Kinase inhibitors and their side effects. We also strive to discuss the monitoring for this class of drugs.
format Article
id doaj-art-e0fc90c6b6ea45ba8719fe006f246317
institution Kabale University
issn 2091-0231
2091-167X
language English
publishDate 2024-10-01
publisher Society of Dermatologists, Venereologists and Leprologists of Nepal (SODVELON)
record_format Article
series Nepal Journal of Dermatology, Venereology & Leprology
spelling doaj-art-e0fc90c6b6ea45ba8719fe006f2463172025-08-23T10:03:30ZengSociety of Dermatologists, Venereologists and Leprologists of Nepal (SODVELON)Nepal Journal of Dermatology, Venereology & Leprology2091-02312091-167X2024-10-0122210.3126/njdvl.v22i2.68527The Emerging World of JAK InhibitorsShraddha Uprety0Chitwan Medical College and Teaching Hospital The Janus Kinase inhibitors are a new emerging class of small molecules. These target the Janus Kinase proteins located on the cell membrane. Janus Kinase proteins regulate the cellular transcription of several proteins and act as mediators in several cytokine pathways. Dysregulation in these cytokine pathways is responsible for disorders like alopecia areata, psoriasis, vitiligo, lichen planus, and more in dermatology. Contrary to the injectable biologics, these Janus kinase inhibitors can be taken per oral route and have greater patient acceptability. In this review, we seek to discuss the various indications of Janus Kinase inhibitors and their side effects. We also strive to discuss the monitoring for this class of drugs. https://www.nepjol.info/index.php/NJDVL/article/view/68527Alopecia areataAtopic DermatitisJAK inhibitorsLichen PlanusPruritusPsoriasis
spellingShingle Shraddha Uprety
The Emerging World of JAK Inhibitors
Nepal Journal of Dermatology, Venereology & Leprology
Alopecia areata
Atopic Dermatitis
JAK inhibitors
Lichen Planus
Pruritus
Psoriasis
title The Emerging World of JAK Inhibitors
title_full The Emerging World of JAK Inhibitors
title_fullStr The Emerging World of JAK Inhibitors
title_full_unstemmed The Emerging World of JAK Inhibitors
title_short The Emerging World of JAK Inhibitors
title_sort emerging world of jak inhibitors
topic Alopecia areata
Atopic Dermatitis
JAK inhibitors
Lichen Planus
Pruritus
Psoriasis
url https://www.nepjol.info/index.php/NJDVL/article/view/68527
work_keys_str_mv AT shraddhauprety theemergingworldofjakinhibitors
AT shraddhauprety emergingworldofjakinhibitors